Trust Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Trust Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-15,535	Closed	-$1.02M	–	93
2015 Q4	$1.02M	Sell	15,535 -450	-3%	-$27.8K	1.23%	35
2015 Q3	$903K	Sell	15,985 -1,125	-7%	-$72.9K	1.03%	48
2015 Q2	$1.01M	Sell	17,110 -370	-2%	-$22.8K	1.03%	49
2015 Q1	$1.09M	Buy	17,480 +9,275	+113%	+$539K	1.08%	45
2014 Q4	$472K	Buy	8,205 +500	+6%	+$27.9K	0.48%	75
2014 Q3	$414K	Buy	7,705 +2,600	+51%	+$138K	0.4%	88
2014 Q2	$268K	Sell	5,105 -1,400	-22%	-$71.6K	0.26%	96
2014 Q1	$344K	Sell	6,505 -4,620	-42%	-$214K	0.35%	90
2013 Q4	$446K	Buy	+11,125	New	+$438K	0.46%	85

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Trust Investment Advisors's TEVA Position: Q1 2016 in Review

Trust Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 15,535 shares — an estimated $1.02M sold.

Trust Investment Advisors first reported a position in TEVA in Q4 2013 and held it in 9 quarters. The position peaked at $1.09M in Q1 2015. 836 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Trust Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Trust Investment Advisors sold 15,535 Teva Pharmaceuticals shares in Q1 2016, an estimated $1.02M.
Trust Investment Advisors first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 9 quarters.
Trust Investment Advisors's Teva Pharmaceuticals position peaked at $1.09M in Q1 2015.
836 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Trust Investment Advisors's 13F filing for Q1 2016, filed 2 May 2016.